UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN ISSUER
PURSUANT TO RULE 13a-16 OR 15b-16 OF
THE SECURITIES EXCHANGE ACT OF 1934
For the month of: March 2018
Commission File Number:
000-51848
Avricore Health Inc.
(Exact name of registrant as specified in its charter)
N/A
(Translation of Registrant’s name into English)
Suite 810 - 789 West Pender Street Vancouver, BC V6C 1H2
CANADA
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F
xo
Form 40-F
o
Indicate by check mark if the Registrant is submitting this Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): Yes
o
No
x
Indicate by check mark if the Registrant is submitting this Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): Yes
o
No
x
Indicate by check mark whether the registrant by furnishing the information contained in this Form 6-K is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934: Yes
o
No
x
Exhibits
The following exhibits are included in this Form 6-K:
Exhibit 99.1
News Release
Exhibit 99.2
Notice of Change of Auditor
Exhibit 99.3
Letter to Commissions, Notice of Change of Auditor
Exhibit 99.4
Letter from Former Auditor
Exhibit 99.5
Letter from Successor Auditor
Exhibit 99.6
Material Change Report
Exhibit 99.7
News Release
Exhibit 99.8
Material Change Report
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
Dated: June 12, 2019
|
AVRICORE HEALTH INC.
|
|
|
|
|
|
By: /s/
Kevin Strong
|
|
|
Kevin Strong
|
|
|
Chief Financial Officer
|
